S. Alyar Et Al. , "Biochemical properties of Schiff bases derived from FDA-approved sulfa drugs: Synthesis, ADME/molecular docking studies, and anticancer activity," Journal of Molecular Structure , vol.1293, 2023
Alyar, S. Et Al. 2023. Biochemical properties of Schiff bases derived from FDA-approved sulfa drugs: Synthesis, ADME/molecular docking studies, and anticancer activity. Journal of Molecular Structure , vol.1293 .
Alyar, S., Alyar, H., ÖZDEMİR ÖZMEN, Ü., Aktaş, O., & ERDEM, K., (2023). Biochemical properties of Schiff bases derived from FDA-approved sulfa drugs: Synthesis, ADME/molecular docking studies, and anticancer activity. Journal of Molecular Structure , vol.1293.
Alyar, Saliha Et Al. "Biochemical properties of Schiff bases derived from FDA-approved sulfa drugs: Synthesis, ADME/molecular docking studies, and anticancer activity," Journal of Molecular Structure , vol.1293, 2023
Alyar, Saliha Et Al. "Biochemical properties of Schiff bases derived from FDA-approved sulfa drugs: Synthesis, ADME/molecular docking studies, and anticancer activity." Journal of Molecular Structure , vol.1293, 2023
Alyar, S. Et Al. (2023) . "Biochemical properties of Schiff bases derived from FDA-approved sulfa drugs: Synthesis, ADME/molecular docking studies, and anticancer activity." Journal of Molecular Structure , vol.1293.
@article{article, author={Saliha Alyar Et Al. }, title={Biochemical properties of Schiff bases derived from FDA-approved sulfa drugs: Synthesis, ADME/molecular docking studies, and anticancer activity}, journal={Journal of Molecular Structure}, year=2023}